Beam Therapeutics Inc. (BEAM)
Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XMEX $
27. 09
-1.82
-6.3%
$
2.54B Market Cap
- P/E Ratio
0% Div Yield
2,140,637 Volume
-5.38 Eps
$ 28.91
Previous Close Day Range
27.03 28.83
Year Range
13.53 35.25
Want to track BEAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days
| BEAM Beam Therapeutics Inc. 24 Feb 2026 (In 2 months) | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 10 Nov 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 4 Nov 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 3 Nov 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 12 Aug 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 5 May 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 25 Feb 2025 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 6 Nov 2024 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 6 Aug 2024 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 7 May 2024 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 26 Feb 2024 | | - Cons. EPS | - EPS |
| BEAM Beam Therapeutics Inc. 6 Nov 2023 | | - Cons. EPS | - EPS |
BEAM Earnings Reports FAQ
What is the earnings per share (EPS) for BEAM?
The current EPS is -5.38.
What is the company's earnings growth rate?
Beam Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-24, based on the BEAM's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Beam Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BEAM at this time, as Beam Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
